CDKN2A / p14ARF Blocking Peptide

Produktübersicht

• Artikelname: CDKN2A / p14ARF Blocking Peptide
• Artikelnummer: FBX-P-P14ARF.100
• Hersteller Artikelnummer: P-P14ARF.100
• Alternativnummer: FBX-P-P14ARF.100-250
• Hersteller: FabGennix
• Kategorie: Biochemikalien
• Applikation: Immunocompetition, Immunodepletion
• Spezies Reaktivität: Human
• Immunogen: N-epitope synthetic peptide corresponding to unique amino acid sequence on p14ARF protein
• Alternative Synonym: alternative reading frame, ARF, CDK4 inhibitor p16-INK4, CDK4I, CDKN2, cell cycle negative regulator beta, CMM2, cyclin-dependent kinase 4 inhibitor A, cyclin-dependent kinase inhibitor 2A, cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4), INK4, INK4A, MLM, MTS1, MTS-1, multiple tumor suppressor 1, P14, P14ARF, P16, P16INK4, P16INK4A, P16-INK4A, P19, P19ARF, TP16

Zusatzinformationen

CDKN2A / p14ARF Blocking Peptide

Produkteigenschaften

• NCBI: 1029
• UniProt: Q8N726
• Target-Kategorie: CDKN2A / p14ARF

Bilder

P-P14ARF.100